2019 Executive Sponsors
2019 Associate Sponsors
2019 Showcase Sponsors
2019 Supporting Sponsors
2019 Supporting & Educational Partners
2019 Media Partners
IO360˚ convenes stakeholders spanning the science and business communities to report on data-driven advancements in immuno-oncology to fight a wider range of cancers.
Immuno-Oncology 360° delivers three key benefits:
- Access to KOLs driving the science
- Partnership opportunities with all stakeholders in Immuno-Oncology
- Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology
Immuno-Oncology 360° provides 10 plenary sessions over the course of 3 days addressing:
2019 Featured Speakers
We would like to welcome Dr Andrew Baum, Citi as part of the 2019 lead advisory committee. Guided by Dr Andrew Baum, along with Dr Axel Hoos, GSK and Dr James Gulley, NCI, the 5th annual Immuno-Oncology 360° program includes more than 80 speakers and over 60 talks.
Immuno-Oncology 360° reports on the most current data and rapid advancements to help IO stakeholders:
If you are interested in participating in the 5th Annual Immuno-Oncology 360° 2019 program, please contact us at firstname.lastname@example.org. Thank you.
"By bringing together groups such as scientists, investors, and experts in clinical trial design and logistics, it creates a forum where there’s quite a lot of folks participating who are not traditionally talking to one another on a daily basis."
- Roy Baynes, MD, PhD, Merck
"I really enjoyed it and connecting with some really interesting and inspiring people with whom I'm sure this is just the beginning of long standing interactions."
- Jacqueline Karmel, Roche
"Thank you again for the amazing invitation, it was truly my pleasure to be able to participate in the excellent event you organized."
- Christine Ward, BMS
"IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"
- Jim Mansfield, PerkinElmer
"Congratulations again on the excellent program for the Immuno-Oncology 360° meeting. It was truly well coordinated and the topics were fantastic!"
- Gilson Baia, PhD, Champions Oncology
"Really good, well-rounded and novel content. Congratulations on filling the house beyond capacity and for securing such an impressive speaking faculty."
- Eileen Daniels, Nektar Therapeutics
"Thank you for a great conference!"
- Elena Spanjaard, Pfizer
"Your team did a wonderful job in putting together an interesting and relevant program."
- Lew Bender, Intensity Therapeutics
"It was a great conference and I was happy to be a part of it."
- Anna Pavlick, DO, MD, NYU Cancer Center